88
Participants
Start Date
May 19, 2022
Primary Completion Date
November 10, 2023
Study Completion Date
November 10, 2023
Seltorexant
Seltorexant 20 mg will be administered orally as a tablet.
Placebo
Matching placebo will be administered orally as a tablet.
Richmond Behavioral Associates, Staten Island
Sonar Clinical Research, Atlanta
NeuroTrials Research Inc, Atlanta
Atlanta Center for Medical Research, Atlanta
Luminous Clinical Research, Homestead
Global Medical Institutes, Miami
Office of Emilio Mantero-Atienza, MD, Miami
Quantix Research, Miami
Entrust Clinical Research, Miami
South Florida Research Center Inc., Miami Springs
Florida International Research Center (FIRC), Miami
P&S Research, LLC, Miami
IMIC Inc, Miami
Biovision Medical, Miami
Accel Clinical Research, Seminole
Intercoastal Medical Group, Sarasota
Vanderbilt University Medical Center, Nashville
Ochsner Medical Center, New Orleans
Gill Neuroscience, Cypress
Wasatch Clinical Research, Salt Lake City
Medical Advancement Center of Arizona, Tempe
Sunwise Clinical Research, Lafayette
Allied Biomedical Research Institute (ABRI), Inc, Miami
Boston Clinical Trials, Boston
Memory Clinic Inc, Bennington
Janssen Research & Development, LLC
INDUSTRY